Lifecore Biomedical Inc. (LFCR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Lifecore Biomedical Inc. (LFCR) has a cash flow conversion efficiency ratio of 0.226x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($4.70 Million) by net assets ($20.78 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Lifecore Biomedical Inc. (LFCR) balance sheet quality index to measure how much of total assets are equity-financed.
Lifecore Biomedical Inc. - Cash Flow Conversion Efficiency Trend (1996–2025)
This chart illustrates how Lifecore Biomedical Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Lifecore Biomedical Inc. cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Lifecore Biomedical Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lifecore Biomedical Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Seshasayee Paper and Boards Limited
NSE:SESHAPAPER
|
-0.036x |
|
Kafrit
TA:KAFR
|
0.104x |
|
Bank Artha Graha Internasional
JK:INPC
|
0.010x |
|
Black Spade Acquisition II Co Unit
NASDAQ:BSIIU
|
-0.002x |
|
Associated Alcohols & Breweries Ltd.
NSE:ASALCBR
|
0.080x |
|
InfuSystems Holdings Inc
NYSE MKT:INFU
|
0.017x |
|
Elektrotim SA
WAR:ELT
|
0.047x |
|
Astral Resources NL
AU:AAR
|
-0.011x |
Annual Cash Flow Conversion Efficiency for Lifecore Biomedical Inc. (1996–2025)
The table below shows the annual cash flow conversion efficiency of Lifecore Biomedical Inc. from 1996 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Lifecore Biomedical Inc..
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-05-31 | $1.34 Million | $-206.00K | -0.154x | -778.86% |
| 2024-05-31 | $11.31 Million | $257.00K | 0.023x | +108.83% |
| 2023-05-31 | $87.82 Million | $-22.59 Million | -0.257x | -13.81% |
| 2022-05-31 | $107.94 Million | $-24.40 Million | -0.226x | -378.28% |
| 2021-05-31 | $202.78 Million | $16.47 Million | 0.081x | +210.12% |
| 2020-05-31 | $231.04 Million | $-17.04 Million | -0.074x | -224.38% |
| 2019-05-31 | $270.14 Million | $16.02 Million | 0.059x | -24.28% |
| 2018-05-31 | $252.56 Million | $19.78 Million | 0.078x | -39.08% |
| 2017-05-31 | $228.15 Million | $29.33 Million | 0.129x | +25.30% |
| 2016-05-31 | $212.35 Million | $21.78 Million | 0.103x | -13.67% |
| 2015-05-31 | $220.11 Million | $26.16 Million | 0.119x | +15.62% |
| 2014-05-31 | $204.76 Million | $21.05 Million | 0.103x | -12.66% |
| 2013-05-31 | $180.41 Million | $21.23 Million | 0.118x | -19.60% |
| 2012-05-31 | $151.56 Million | $22.18 Million | 0.146x | +39.31% |
| 2011-05-31 | $137.73 Million | $14.47 Million | 0.105x | +85.99% |
| 2010-05-31 | $132.47 Million | $7.48 Million | 0.056x | -23.85% |
| 2009-05-31 | $127.20 Million | $9.44 Million | 0.074x | -50.88% |
| 2008-05-31 | $116.02 Million | $17.52 Million | 0.151x | +920.78% |
| 2007-05-31 | $112.07 Million | $-2.06 Million | -0.018x | -114.70% |
| 2006-05-31 | $86.82 Million | $10.87 Million | 0.125x | -29.48% |
| 2005-05-31 | $73.53 Million | $13.05 Million | 0.177x | +41.16% |
| 2004-05-31 | $63.10 Million | $7.93 Million | 0.126x | +7262.63% |
| 2002-05-31 | $57.54 Million | $-101.00K | -0.002x | +98.82% |
| 2001-05-31 | $50.87 Million | $-7.57 Million | -0.149x | -269.33% |
| 2000-05-31 | $57.00 Million | $5.01 Million | 0.088x | +177.61% |
| 1999-05-31 | $31.80 Million | $-3.60 Million | -0.113x | -12.21% |
| 1998-05-31 | $33.70 Million | $-3.40 Million | -0.101x | +34.70% |
| 1997-05-31 | $35.60 Million | $-5.50 Million | -0.154x | -57.07% |
| 1996-05-31 | $36.60 Million | $-3.60 Million | -0.098x | -- |
About Lifecore Biomedical Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device … Read more